173 related articles for article (PubMed ID: 6810628)
1. Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
Mantovani G; Del Giacco GS; Marongiu F; Tognella S; Carassi UE
Acta Haematol; 1982; 67(4):287-8. PubMed ID: 6810628
[No Abstract] [Full Text] [Related]
2. Drug selection in the treatment of Hodgkin's disease.
Bonadonna G; Santoro A
Hematol Oncol; 1983; 1(1):3-12. PubMed ID: 6203820
[No Abstract] [Full Text] [Related]
3. [Acute leukemia in patients treated for Hodgkin's disease].
Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
[No Abstract] [Full Text] [Related]
4. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
5. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
6. [10 years of DeVita protocol].
Gassmann W; Schmitz N; Löffler H
Dtsch Med Wochenschr; 1982 Jul; 107(27):1043-4. PubMed ID: 6896303
[No Abstract] [Full Text] [Related]
7. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
Luce JK; Frei E; Gehan EA; Coltman CA; Talley R; Monto RW
Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037
[No Abstract] [Full Text] [Related]
8. Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.
Brandriff BF; Meistrich ML; Gordon LA; Carrano AV; Liang JC
Hum Genet; 1994 Mar; 93(3):295-9. PubMed ID: 8125481
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
[No Abstract] [Full Text] [Related]
11. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
12. Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
Farney RJ; Morris AH; Armstrong JD; Hammer S
Am Rev Respir Dis; 1977 Jan; 115(1):135-45. PubMed ID: 835882
[TBL] [Abstract][Full Text] [Related]
13. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
14. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
15. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
Casini M; Pianezze G; Fabris P; Cemin S; Coser P
Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
[No Abstract] [Full Text] [Related]
16. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G
Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
[TBL] [Abstract][Full Text] [Related]
17. Acute pneumonitis associated with MOPP chemotherapy of Hodgkin's disease.
Cersosimo RJ; Licciardello JT; Matthews SJ; Bromer R; Hong WK
Drug Intell Clin Pharm; 1984; 18(7-8):609-11. PubMed ID: 6101251
[TBL] [Abstract][Full Text] [Related]
18. Multiple-drug therapy in Hodgkin's disease.
Rubens RD; Wiltshaw E; Boesen E; Galton DA
Eur J Cancer (1965); 1972 Oct; 8(5):477-84. PubMed ID: 4651783
[No Abstract] [Full Text] [Related]
19. Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
Lavey RS
J Clin Oncol; 1990 Dec; 8(12):2089-90. PubMed ID: 2230901
[No Abstract] [Full Text] [Related]
20. [Acute myeloid leukemia after treatment of Hodgkin's disease].
Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
